Ikarian Capital, LLC Ocuphire Pharma, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.8 - $3.25 $223,237 - $403,068	-124,021 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.75 - $4.39 $16,384 - $26,155	5,958 Added 5.05%	124,021 $401,000
Q3 2021 Nov 15, 2021	SELL	$3.84 - $5.38 $5,713 - $8,005	-1,488 Reduced 1.24%	118,063 $608,000
Q1 2021 May 17, 2021	BUY	$5.7 - $13.31 $681,440 - $1.59 Million	119,551 New	119,551 $693,000

2.58M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.